RecruitingNCT07580144

Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients


Sponsor

Konya Meram State Hospital

Enrollment

100 participants

Start Date

May 13, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective observational study aims to evaluate whether sarcopenia and frailty affect the pharmacodynamic profile of rocuronium in geriatric patients undergoing elective surgery under general anesthesia.


Eligibility

Min Age: 65 YearsMax Age: 80 Years

Inclusion Criteria6

  • Scheduled to undergo elective surgery under general anesthesia requiring endotracheal intubation
  • Planned use of rocuronium for neuromuscular blockade
  • Quantitative neuromuscular monitoring planned during anesthesia
  • American Society of Anesthesiologists physical status I-III
  • Ability to provide written informed consent
  • Completion of preoperative frailty and sarcopenia assessment

Exclusion Criteria10

  • Emergency surgery
  • Known neuromuscular disease
  • History of allergy or contraindication to rocuronium, sugammadex
  • Severe hepatic insufficiency
  • Severe renal insufficiency
  • Use of drugs known to significantly affect neuromuscular transmission
  • Preoperative mechanical ventilation or intensive care unit admission
  • Inability to perform a frailty or sarcopenia assessment
  • Patients in whom quantitative neuromuscular monitoring cannot be properly performed
  • Refusal to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Betul Kozanhan

Konya, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07580144


Related Trials